L-DOPA-Induced Modulation of GABA and Glutamate Release in Substantia Nigra Pars Reticulata in a Rodent Model of Parkinson's Disease

Synapse

Volumn 52, Issue 2, 2004, Pages 163-165

  Ochi, Mayumi ^a   Shiozaki, Shizuo ^a   Kase, Hiroshi ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; LEVODOPA; OXIDOPAMINE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; 4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DRUG MECHANISM; GABAERGIC TRANSMISSION; GLOBUS PALLIDUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RODENT; SUBSTANTIA NIGRA;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; LEVODOPA; MALE; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 1842458272     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20006     Document Type: Article

References (14)

1. Abarca J, Gysling K, Roth RH, Bustos G. 1995. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies. Neurochem Res 20:159-169.
2. Benazzouz A, Hallett M. 2000. Mechanism of action of deep brain stimulation. Neurology 55:S13-S16.
3. 2A receptor antagonist istradefylline in advanced PD. Neurology 61:297-303.
4. 2A receptor in basal ganglia. Biosci Biotechnol Biochem 65:1447-1457.
5. 2A receptor antagonist KW-6002: research and development toward a novel non-dopaminergic therapy for Parkinson's disease. Neurology 61(Suppl 6):S97-100.
6. Marti M, Sbrenna S, Fuxe K, Bianchi C, Beani L, Morari M. 2000. Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats. Eur J Neurosci 12:1848-1850.
7. 2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J Neurosci 15:605-611.
8. Myers CS, Fisher H, Wagner GC. 1995. Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats. Pharmacol Biochem Behav 52:749-753.
9. 2A receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study. Neuroscience 100:53-62.
10. 2A receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease. Neuroscience (in press).
11. Orosz D, Bennett JP. 1992. Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat. Exp Neurol 115:388-393.
12. Robertson GS, Robertson HA. 1989. Evidence that L-DOPA-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9:3326-3331.
13. A-mediated IPSCs in the rat globus pallidus. J Physiol (Lond) 532:423-434.
14. Windels F, Bruet N, Poupard A, Urbain N, Chouvet G, Feuerstein C, Savasta M. 2000. Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur J Neurosci 12: 4141-4146.